There are significant differences in the diagnosis and management of heart failure between general practitioners and cardiologists, with GPs relying more on clinical grounds and diuretics, while cardiologists utilize echocardiography and guideline-directed medical therapy more frequently.
Answers are grounded in this paper and cite their sources.
Observed prescribing differences should not yet change practice; hypothesis-generating for education to align GP and cardiologist HF care.
Heart failure has gradually become one of the most prevalent cardiovascular disorders in Western Societies, notably in the elderly 1,2. Notwithstanding the public health importance of heart failure, current management of heart failure in clinical practice seems far from optimal 3–6. Data on perceptions 7–9, diagnosis and management of patients with heart failure, in every day care are, however, scarce 10,11. In particular, studies comparing primary and secondary care are virtually non-existent 10. To compare perceptions about heart failure diagnosis and management, between cardiologists and general practitioners (GPs) in the Netherlands. In the year 2000, 150 GPs in the Netherlands were sent a questionnaire. The practices were located in the vicinity of Utrecht, were both urban and rural, and included single-handed and group practices. In total, 99 (62%) of the GPs participated. Forty-five (45%) of the participating GPs also took part in our study using patient files (see paper by Rutten et al. in this issue). All invited GPs routinely register their patient contacts in ELIAS (SMS Cendata Nieuwegein); a software package suitable for electronic registration of medical information. In addition, 58 cardiologists were sent a questionnaire. Cardiologists were selected at random from one academic, three middle size, and five smaller hospitals in the Netherlands. Thirty-six (62%) cardiologists participated. Twenty-four (67%) of the participating cardiologists also took part in our study on patient files (see paper by Rutten et al. in this issue). The questionnaire contained 21 questions, with dichotomous response options, concerning aspects of the diagnosis and management of heart failure. The study was conducted as part of the Utrecht heart failure organisation. Approval of the study was obtained from the Ethics Committee of the University Medical Center Utrecht, the Netherlands. Differences in proportions were assessed by means of χ2 tests. All analyses were undertaken using SPSS for WINDOWS version 9.0 (SPSS, Chicago, Illinois). Prior myocardial infarction (69 vs. 83%) and hypertension (59 vs. 72%) are seen as important features in history by both GPs and cardiologists (Table 1). Of symptoms, dyspnoea (81 vs. 97%), and peripheral oedema (77 vs. 72%) are qualified as most important by both. Pulmonary crepitations (93 vs. 92%), peripheral oedema (90 vs. 81%), and the presence of an elevated jugular venous pressure (69 vs. 67%) are considered important signs (Table 1). In addition, cardiologists pay relatively more attention to heart murmurs (16 vs. 36%) and a third heart sound (12 vs. 44%) than GPs. Chest radiography (98 vs. 100%) and electrocardiography (85 vs. 94%) are used most often as additional diagnostic investigations, in both primary and secondary care. As a subsequent diagnostic tool, GPs prefer a change in symptoms following test treatment with diuretics (97 vs. 49%), while cardiologists prefer (Doppler) echocardiography (62 vs. 100%) and coronary angiography (15 vs. 81%) (Table 2). Currently, neuropeptides (such as atrial natriuretic peptide (ANP) or brain natriuretic peptide (BNP)) do not play an important role as a diagnostic tool in heart failure (Table 2). As first choice medical treatment GPs prescribe diuretics (63 vs. 29%, P=0.001), while cardiologists primarily prefer a combination of ACE inhibitor and diuretics (32 vs. 63%, P=0.001). All cardiologists (100%), but only 35% of the GPs ever prescribe β-blockers for heart failure. In case of persisting symptoms in patients being treated with diuretics and ACE inhibitors, GPs add spironolactone and digoxin, while cardiologists also use β-blockers or angiotensin II antagonists as additional therapy (Table 3). There were no significant differences between GPs who participated in the patient files study (see paper by Rutten et al. in this issue) and the other GPs. Also, between cardiologists who participated in the patient files study and those who did not, answers to the questions in the questionnaire did not differ significantly. Differences in diagnosis and management of heart failure between GPs and cardiologists primarily concern preferences in additional investigations and pharmacological interventions. GPs tend to diagnose heart failure on clinical grounds, not making use of echocardiography facilities. This tendency has also been observed in other studies 7,9,11. Limited access to echocardiography for primary care patients is probably an explanation for this discrepancy. At the moment neuropeptides, such as ANP and BNP do not play an important role in either primary or secondary care in the Netherlands, although studies have shown their potential usefulness as a diagnostic tool 12–15. Our study shows that GPs often rely on a ‘positive’ reaction following initiation of diuretics as a diagnostic tool in suspected heart failure. Although several guidelines, including the European Society of Cardiology mention improvement in symptomatology following appropriate therapy as an important diagnostic sign 16, its diagnostic value is unknown and should be assessed. In contrast to cardiologists, most GPs consider monotherapy with diuretics an important option in heart failure treatment. In addition, GPs are reluctant to prescribe β-blocking agents. Differences between primary and secondary care populations could play a role in these preferences of the GPs, because on average, primary care patients are 10–15 years older and more often female 4,5,7,17,18. We thank the participating general practitioners, internists and cardiologists. In addition, we thank Diana Balk, Renate Siebes and Peter Zuithoff for administrative assistance and statistical help, and Geert van der Heijden for critically reading the manuscript. Financial support for this study was obtained from the Dutch Heart Foundation, grant number 48006.
No takes yet. Share an insight, caveat, or question.
Rutten et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: